Célérier Evelyne, González Juan R, Maldonado Rafael, Cabañero David, Puig Margarita M
Anesthesiology Research Unit, Instituto Municipal de Investigaciones Médicas, Barcelona, Spain.
Anesthesiology. 2006 Mar;104(3):546-55. doi: 10.1097/00000542-200603000-00023.
Opioid-induced delayed hyperalgesia and allodynia have been reported in human and animal models. The authors evaluated the influence of different opioids used during clinical anesthesia on nociceptive sensitivity and incisional pain in mice. The role of the inducible nitric oxide synthase on surgical pain and opioid-induced pronociception also was investigated.
CD1 mice were used to study the efficacy of opioids inducing pronociception and enhancing incisional pain. The implication of nitric oxide generated from the inducible nitric oxide synthase was investigated using knockout mice (C57/BL6) for its gene. Mice underwent right hind paw surgery under sevoflurane anesthesia combined with subcutaneous administration of saline or the opioids fentanyl (0.05 mg/kg), alfentanil (1 mg/kg), and remifentanil (0.04 mg/kg). Nociception was evaluated daily for 7 days using paw-pressure, plantar, and von Frey tests.
The antinociceptive effect of opioids was followed by long-lasting thermal hyperalgesia and mechanical allodynia (each lasting between 2 and 7 days), but not mechanical hyperalgesia. Intraoperative infusion of opioids significantly enhanced incisional pain in all tests. The most prominent effects were observed with remifentanil. The inducible nitric oxide synthase gene deletion attenuated both remifentanil- and incision-induced pronociceptive effects. In mutant mice for the inducible nitric oxide synthase gene, remifentanil was still efficient in enhancing incisional pain, but the global pronociceptive effect was attenuated significantly as compared with wild-type mice.
The authors' study demonstrates that the intraoperative administration of fentanyl or remifentanil enhances the extent and duration of postoperative pain. The results suggest a role of the nitric oxide systems in the cause of acute postoperative pain and opioid-induced pronociception.
在人类和动物模型中均已报道阿片类药物诱导的延迟性痛觉过敏和痛觉异常。作者评估了临床麻醉期间使用的不同阿片类药物对小鼠伤害性感受敏感性和切口疼痛的影响。还研究了诱导型一氧化氮合酶在手术疼痛和阿片类药物诱导的促痛作用中的作用。
使用CD1小鼠研究阿片类药物诱导促痛和加重切口疼痛的效果。使用诱导型一氧化氮合酶基因敲除小鼠(C57/BL6)研究由诱导型一氧化氮合酶产生的一氧化氮的作用。小鼠在七氟醚麻醉下接受右后爪手术,并皮下注射生理盐水或阿片类药物芬太尼(0.05mg/kg)、阿芬太尼(1mg/kg)和瑞芬太尼(0.04mg/kg)。使用爪压力、足底和von Frey试验每天评估伤害性感受,持续7天。
阿片类药物的镇痛作用之后是持久的热痛觉过敏和机械性痛觉异常(每种持续2至7天),但没有机械性痛觉过敏。术中输注阿片类药物在所有测试中均显著加重切口疼痛。瑞芬太尼的效果最为显著。诱导型一氧化氮合酶基因缺失减弱了瑞芬太尼和切口诱导的促痛作用。在诱导型一氧化氮合酶基因的突变小鼠中,瑞芬太尼在加重切口疼痛方面仍然有效,但与野生型小鼠相比,整体促痛作用显著减弱。
作者的研究表明,术中给予芬太尼或瑞芬太尼会增加术后疼痛的程度和持续时间。结果表明一氧化氮系统在急性术后疼痛和阿片类药物诱导的促痛作用中起作用。